-transparent.png){kind=logo}
OBJECTIVE A clear line cannot be drawn between well-differentiated and anaplastic astrocytomas, and a subset of low-grade tumors, histologically indistinguishable from the others, behaves similarly to anaplastic astrocytomas. The proliferative index could aid in the identification of this subgroup, for which a different therapeutic approach would be indicated. METHODS We immunohistochemically evaluated the proliferating cell nuclear antigen (PCNA) expression in 77 well-differentiated astrocytomas, since PCNA has been considered a good proliferation marker. The prognostic significance of PCNA labeling index (LI) was assessed in univariate and multivariate analysis, taking into consideration some clinical and histologic factors known to affect prognosis. RESULTS PCNA immunostaining identified a subgroup of tumors, characterized by a LI > 5%, with a median survival close to that observed in anaplastic astrocytomas. The survival table of such a group was significantly different from that of the group with a lower LI (p = 0.0009). Multivariate analysis confirmed that PCNA-LI is an independent prognostic factor (p = 0.001). CONCLUSIONS These data suggest that PCNA immunostaining can be a useful tool to define the prognosis of low-grade astrocytomas on routine biopsy material.
M C Vigliani, and
A Chiò, and
T Pezzulo, and
R Soffietti, and
M T Giordana, and
D Schiffer
October 1994,
Histopathology,
M C Vigliani, and
A Chiò, and
T Pezzulo, and
R Soffietti, and
M T Giordana, and
D Schiffer
February 1995,
International journal of oncology,
M C Vigliani, and
A Chiò, and
T Pezzulo, and
R Soffietti, and
M T Giordana, and
D Schiffer
September 1996,
Annales de pathologie,
M C Vigliani, and
A Chiò, and
T Pezzulo, and
R Soffietti, and
M T Giordana, and
D Schiffer
October 1998,
Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India,
M C Vigliani, and
A Chiò, and
T Pezzulo, and
R Soffietti, and
M T Giordana, and
D Schiffer
December 1996,
Japanese journal of clinical oncology,
M C Vigliani, and
A Chiò, and
T Pezzulo, and
R Soffietti, and
M T Giordana, and
D Schiffer
April 1993,
Acta medica Okayama,
M C Vigliani, and
A Chiò, and
T Pezzulo, and
R Soffietti, and
M T Giordana, and
D Schiffer
January 1999,
Hepato-gastroenterology,
M C Vigliani, and
A Chiò, and
T Pezzulo, and
R Soffietti, and
M T Giordana, and
D Schiffer
April 1987,
Ryumachi. [Rheumatism],
M C Vigliani, and
A Chiò, and
T Pezzulo, and
R Soffietti, and
M T Giordana, and
D Schiffer
November 1994,
International journal of cancer,
M C Vigliani, and
A Chiò, and
T Pezzulo, and
R Soffietti, and
M T Giordana, and
D Schiffer
May 1995,
Medical and pediatric oncology,
